Skip to main content

Find Clinical Trials

Home
Conditions
Receptor, Fibroblast Growth Factor, Type 3

Clinical trial condition

Receptor, Fibroblast Growth Factor, Type 3

Explore clinical trials studying Receptor, Fibroblast Growth Factor, Type 3. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Receptor, Fibroblast Growth Factor, Type 3 trial results

Not yet recruiting

A Study of Vepugratinib (LY3866288) in Adults With Non-Muscle Invasive Bladder Cancer and Upper Tract Urothelial Cancer

NCT07827612

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations: Carolina Urologic Research Center, LLC Myrtle Beach, South Carolina, United States

View Trial Details